Tweet
<img alt="" height="1" width="1" />
Sanofi reports positive results with diabetes pill
BusinessWeek
Sanofi-Aventis said Monday that a study of its experimental diabetes drug showed better blood sugar control than a dummy pill. The study included 361 patients with type 2 diabetes who randomly received either lixisenatide, the company's diabetes pill, ...
Sanofi-Aventis Announces Results Of Phase III Study On LixisenatideWall Street Journal
Zealand Pharma: Positive Study Findings from Lixisenatide in First Phase III ...Reuters (press release)
Sanofi upbeat on GLP-1 diabetes drug data; Emergent wins $186M contract ...FierceBiotech
RTT News -eMaxHealth -Drug Store News
all 49 news articles »
More...